Format

Send to

Choose Destination
See comment in PubMed Commons below
Drug News Perspect. 2010 Mar;23(2):99-103. doi: 10.1358/dnp.2010.23.2.1475899.

Therapeutic potential of histamine H3 receptor antagonists in dementias.

Author information

  • 1Integrative Neuroscience, School of Biological & Biomedical Sciences, Durham University, Durham, UK. paul.chazot@dur.ac.uk

Abstract

Selective antagonism of centrally localized histamine H(3) receptors has been shown to enhance the release of a wide spectrum of important neurotransmitters including acetylcholine, gamma-aminobutyric acid, dopamine and noradrenalin, among others, which play fundamental roles in cognitive processes, in an output-dependent manner. The cognitive-enhancing effects of H(3) receptor antagonists across multiple cognitive domains in a wide number of preclinical cognition models also endow confidence in this therapeutic strategy for the treatment of Alzheimer's disease, attention deficit hyperactivity disorder and the cognitive deficits often expressed in schizophrenia. Recent positive clinical reports are beginning to reinforce this optimism.

Copyright 2010 Prous Science, S.A.U. or its licensors. All rights reserved.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Prous Science
    Loading ...
    Write to the Help Desk